Self-assembled nanoparticles conjugated with various imaging contrast agents have been used for the detection and imaging of pathologic tissues. Inadvertently, these nanoparticles undergo fast, dilution-induced disintegration in circulation and quickly lose their capability to associate with and image the site of interest. To resolve this challenge, we hypothesize that decreasing the bilayer permeability of polymersomes can stabilize their structure, extend their lifetime in circulation, and hence improve the quality of bioimaging when the polymersome is coupled with an imaging probe. This hypothesis is examined by using poly(2-hydroxyethyl-co-octadecyl aspartamide), sequentially modified with methacrylate groups, to build model polymersomes. The bilayer permeability of the polymersome is decreased by increasing the packing density of the bilayer with methacrylate groups and is further decreased by inducing chemical cross-linking reactions between the methacrylate groups. The polymersome with decreased bilayer permeability demonstrates greater particle stability in physiological media and ultimately can better highlight tumors in mice over 2 days compared to those with higher bilayer permeability after labeling with a near-infrared (NIR) fluorescent probe. We envisage that the resulting nanoparticles will not only improve diagnosis but also further image-guided therapies.
Self-assembled nanoparticles conjugated with various imaging contrast agents have been used for the detection and imaging of pathologic tissues. Inadvertently, these nanoparticles undergo fast, dilution-induced disintegration in circulation and quickly lose their capability to associate with and image the site of interest. To resolve this challenge, we hypothesize that decreasing the bilayer permeability of polymersomes can stabilize their structure, extend their lifetime in circulation, and hence improve the quality of bioimaging when the polymersome is coupled with an imaging probe. This hypothesis is examined by using poly(2-hydroxyethyl-co-octadecyl aspartamide), sequentially modified with methacrylate groups, to build model polymersomes. The bilayer permeability of the polymersome is decreased by increasing the packing density of the bilayer with methacrylate groups and is further decreased by inducing chemical cross-linking reactions between the methacrylate groups. The polymersome with decreased bilayer permeability demonstrates greater particle stability in physiological media and ultimately can better highlight tumors in mice over 2 days compared to those with higher bilayer permeability after labeling with a near-infrared (NIR) fluorescent probe. We envisage that the resulting nanoparticles will not only improve diagnosis but also further image-guided therapies.
Extensive efforts have
been made to detect pathologic tissues (i.e.,
proinflammatory tissue, tumors) at an early stage, as treatment is
more effective when they are found early.[1,2] Common
methods of diagnosis currently include biochemical screening of blood
samples or whole body imaging.[3] Specifically,
whole body imaging offers several advantages, including the ability
to locate the pathologic tissue and further assess therapeutic outcomes
in a noninvasive manner. Biomedical imaging techniques that are used
commonly in preclinical and clinical settings, including magnetic
resonance imaging,[4] optical coherence tomography,[5,6] and near-infrared (NIR) fluorescence imaging,[7,8] often
employ molecules or nanoparticles that can provide enhanced image
contrast.[4−8] Furthermore, efforts are increasingly made to deliver these imaging
contrast agents exclusively to the target tissue in order to pinpoint
it using conventional imaging modalities.One popular approach
is to conjugate imaging contrast agents to
nanoparticles that can diffuse through the leaky inflamed or tumor
vasculature and accumulate in the extravascular tissue, termed as
the enhanced permeability and retention (EPR) effect.[9,10] Alternatively, nanoparticles conjugated with ligands can bind actively
with receptors overexpressed by target pathologic cells.[4−6] Integrating the EPR effect with the active targeting is also being
explored in the design of advanced nanoparticles targeting tissues
of interest. These efforts, however, are often plagued by the limited
circulation time of the self-assembled nanoparticles in vivo.[11] For example, in mice and rats, nanoparticles
should continue circulating for at least 6 h to achieve the desired
EPR effect.[12] Accordingly, a variety of
approaches have been developed to increase the circulation time of
nanoparticles equipped with imaging contrast agents in the bloodstream.
For instance, the nanoparticle surface is conjugated with poly(ethylene
glycol) (PEG) to reduce the mononuclear phagocyte system-mediated
clearance.[13] Separately, the molecular
weights of nanoparticle-forming molecules can be tailored to improve
the structural integrity of nanoparticles: nanoparticles formed from
the self-assembly of high molecular weight polymers remained more
stable than small molecular weight molecules, such as lipids and surfactants.[14] These approaches are often combined together
to attain synergistic improvements of the particle stability.However, self-assembled polymeric micelles were still reported
to disintegrate quickly in the circulation due to dilution effects.
For example, poly(caprolactone)-b-poly(ethylene oxide)
and poly(d,l-lactide)-b-methoxypoly(ethylene
glycol) micelles were found to dissociate within 1 h under biological
conditions.[15,16] Similar to the polymeric micelle,
it is highly plausible that polymeric vesicles, termed polymersomes,
would also quickly dissociate in circulation before achieving an effective
accumulation in target tissues. To resolve this challenge, we hypothesized
that reducing the bilayer permeability of polymersomes would greatly
enhance the particle structural stability in circulation. Accordingly,
the particles with a reduced permeability would enhance the quality
of image-based diagnosis of pathologic tissues. We examined this hypothesis
by introducing a controlled number of methacrylate groups into the
bilayer of polymersomes formed from the self-assembly of poly(2-hydroxyethyl-co-octadecyl aspartamide) (PHEA-C18), because
methacrylate groups can associate with each other and increase the
packing density of the bilayer (Scheme 1).
In addition, after particle assembly, the methacrylate groups were
cross-linked to further decrease the bilayer permeability. Afterward,
the polymer was further modified with an NIR fluorescent probe, FPR-675,
and the capability of the resulting polymersome in detecting and imaging
pathologic tissues was evaluated by systemically injecting them into
a mousetumor model of squamous cell carcinoma.[8,17] In
summary, this study should greatly serve to expand the lifetime of
polymersomes under physiological conditions, contribute to the early
detection of pathologic tissues, and hence take image-based diagnostics
to the next level.
Scheme 1
Schematic Description of the Structure of a Poly(2-hydroxyethyl-co-2-methacryloxyethyl-co-octadecyl
aspartamide) (PHEA-C18-MA) Polymersome, in Which the Bilayer
Became Less Permeable Due to the Increased Packing Density Resulting
from the Higher Degree of Substitution of Methacrylate (DSMA) and from the Cross-Linking of Methacrylate Groups
Results
Preparation and Characterizations
of PHEA-C18 and
PHEA-C18-MA
Poly(2-hydroxyethyl-co-2-methacryloxyethyl-co-octadecyl aspartamide) (PHEA-C18-MA) was synthesized by modifying polysuccinimide (PSI) with
octadecyl chains and methacrylate groups. PSI was prepared via the
acid-catalyzed polycondensation of l-aspartic acid.[18] The successive reactions of PSI with the designated
amounts of octadecylamine and 2-aminoethyl methacrylate hydrochloride
resulted in PSI substituted with octadecyl and methacrylate groups
(Scheme 2, PSI-C18-MA). Subsequent
addition of an excess of ethanolamine to the polymer solution led
to the substitution of all remaining succiminide units with hydroxyl
groups (Scheme 2, PHEA-C18-MA),
as confirmed with 1H NMR (Supporting
Information Figure S1). Separately, PHEA-C18-MA
without methacrylate groups (PHEA-C18) and unalkylated
poly(2-hydroxyethyl aspartamide) (PHEA) were synthesized as control
polymers.
Scheme 2
Synthesis of PHEA-C18-MA, Where the Polymer
Backbone Was
Substituted with Octadecyl Chains and a Varying Degree of Substitution
of Methacrylate
DSMA, denoted as
‘z’ in the scheme; z = 0 for PHEA-C18. x and y in the reaction
scheme represent the degree of substitution of hydroxyl groups and
the degree of substitution of octadecyl chains (DSC18),
respectively.
Synthesis of PHEA-C18-MA, Where the Polymer
Backbone Was
Substituted with Octadecyl Chains and a Varying Degree of Substitution
of Methacrylate
DSMA, denoted as
‘z’ in the scheme; z = 0 for PHEA-C18. x and y in the reaction
scheme represent the degree of substitution of hydroxyl groups and
the degree of substitution of octadecyl chains (DSC18),
respectively.Determined with
the 1H NMR spectra of the polymers.Determined by dynamic light scattering
(DLS). The particles were suspended in deionized water. Data represented
are the average values followed by the standard deviation from three
independent experiments.The degree of substitution of octadecyl chains (DSC18)
of PHEA-C18 and PHEA-C18-MApolymers, defined
as the mole percent of succinimide units substituted with octadecyl
chains, was tuned to the range from 36 to 37 mol % according to the
integrals of the characteristic NMR peaks at 0.85 to 0.95 ppm and
4.3 to 4.7 ppm (Supporting Information Figure
S1 and Table 1). The peak at 0.85 to
0.95 ppm represents the protons of methyl groups at the ends of the
substituted octadecyl chains, and the peak at 4.3 to 4.7 ppm is due
to the protons on the polymer backbone. Additionally, the degree of
substitution of methacrylate (DSMA) of PHEA-C18-MA, defined as the mole percent of succinimide units reacted with
2-aminoethy methacrylate hydrochloride, was tuned to 2.7 and 4.8 mol
%, as quantified by the integrals of the characteristic NMR peaks
at 4.3 to 4.7, 5.7, and 6.1 ppm. The peaks at 5.7 and 6.1 ppm represent
the two protons on the vinyl carbon of the substituted methacrylate,
and the peak at 4.3 to 4.7 ppm represents the protons on the polymer
backbone (Supporting Information Figure S1). For convenience, PHEA-C18 and PHEA-C18-MApolymers at DSMA of 2.7 and 4.8 mol % are termed as MA-0.0,
MA-2.7, and MA-4.8, respectively.
Table 1
Molecular Analysis
of PHEA-C18 and PHEA-C18-MA with Controlled
DSMA
hydrodynamic
radius (RH, nm)b
sample
DSC18 [mol %]a
DSMA [mol %]a
not cross-linked
cross-linked
MA-0.0
36.7
0.0
102 ± 2
MA-2.7
36.4
2.7
102 ± 8
99 ± 3
MA-4.8
36.9
4.8
90 ± 5
85 ± 5
Determined with
the 1H NMR spectra of the polymers.
Determined by dynamic light scattering
(DLS). The particles were suspended in deionized water. Data represented
are the average values followed by the standard deviation from three
independent experiments.
Pyrene-based fluorescence analysis of
polyaspartamide polymersomes.
(a) The fluorescence intensity ratio while the pyrene was incorporated
into a suspension of MA-0.0, MA-2.7, MA-4.8, and PHEA in phosphate
buffered saline (PBS), respectively. (b) The critical aggregation
concentration (CAC), marked by the turning point of I3/I1 values in part a, of MA-0.0, MA-2.7, and MA-4.8 in PBS.The ability of MA-0.0, MA-2.7,
and MA-4.8 to self-associate in
aqueous media was analyzed by the emission intensity of pyrene incorporated
into the hydrophobic domain of the polymeric assembly. It is common
to assess the critical aggregation concentration (CAC) of amphiphilic
molecules by measuring the increase in the pyrene emission intensity
ratio (I3/I1) between 385 (I3) and
373 (I1) nm.[19] Pyrene mixed
with unalkylated PHEA, formed by PSI substituted solely with hydroxyl
groups, showed an insignificant increase in I3/I1 with the increasing polymer concentration, while the pyrene incorporated
into a suspension of MA-0.0 showed an increase of I3/I1 at a CAC of 5 × 10–2 mg/mL (Figure 1a). Furthermore, the CAC value was found to be inversely
related to DSMA of the studied polymer (Figure 1b).
Figure 1
Pyrene-based fluorescence analysis of
polyaspartamide polymersomes.
(a) The fluorescence intensity ratio while the pyrene was incorporated
into a suspension of MA-0.0, MA-2.7, MA-4.8, and PHEA in phosphate
buffered saline (PBS), respectively. (b) The critical aggregation
concentration (CAC), marked by the turning point of I3/I1 values in part a, of MA-0.0, MA-2.7, and MA-4.8 in PBS.
Preparation and Analysis of PHEA-C18 and PHEA-C18-MA Polymersomes
PHEA-based polymersomes
were prepared
by a solvent exchange process (Supporting Information
Figure S2). Irgacure 2959 and polymers were first dissolved
in dimethyl sulfoxide (DMSO) to provide chain mobility sufficient
for intermolecular self-assembly in aqueous media. The subsequent
introduction of this mixture into deionized water and the removal
of DMSO by dialysis resulted in spherical polymersomes, as confirmed
with transmission electron microscopy (TEM). The polymersome suspension
was further exposed to ultraviolet (UV) light to activate the cross-linking
reaction within the bilayer of the polymersome. No significant difference
of the particle morphology was found between the polymersome before
(Figure 2a) and after (Figure 2b) the exposure to UV light.
Figure 2
Morphology
characterization and bilayer permeability analysis of
polyaspartamide polymersomes. (a) TEM micrographs of the self-assembled
polymersomes of (I) MA-0.0, (II) MA-2.7, and (III) MA-4.8, for which
all of the bilayers were not cross-linked. (b) TEM micrographs of
the self-assembled polymersomes of (I) MA-2.7 and (II) MA-4.8. The
bilayers of MA-2.7 and MA-4.8 polymersomes were cross-linked. All
scale bars in parts a and b represent 200 nm. (c) Calcein-based fluorescence
analysis of MA-2.7 and MA-4.8 polymersomes, either with cross-linked
(CL) or without cross-linked (NCL) bilayers. The filled and open bars
represent polymersomes incubated in deionized water and in deionized
water supplemented with plasma (10%, v/v), respectively.
The average radii of MA-0.0,
MA-2.7, and MA-4.8 polymersomes were also measured with dynamic light
scattering (DLS) (Table 1). No significant
difference in the average hydrodynamic radius (RH) was found between MA-0.0 or MA-2.7 polymersomes with or
without a cross-linked bilayer. However, increasing the DSMA from 2.7 mol % to 4.8 mol % resulted in a decrease of RH from 102 to 90 nm and from 99 to 85 nm for the polymersome
without cross-linked bilayers and those with, respectively.Morphology
characterization and bilayer permeability analysis of
polyaspartamide polymersomes. (a) TEM micrographs of the self-assembled
polymersomes of (I) MA-0.0, (II) MA-2.7, and (III) MA-4.8, for which
all of the bilayers were not cross-linked. (b) TEM micrographs of
the self-assembled polymersomes of (I) MA-2.7 and (II) MA-4.8. The
bilayers of MA-2.7 and MA-4.8 polymersomes were cross-linked. All
scale bars in parts a and b represent 200 nm. (c) Calcein-based fluorescence
analysis of MA-2.7 and MA-4.8 polymersomes, either with cross-linked
(CL) or without cross-linked (NCL) bilayers. The filled and open bars
represent polymersomes incubated in deionized water and in deionized
water supplemented with plasma (10%, v/v), respectively.We further analyzed how the DSMA and
the subsequent
cross-linking reaction influenced the bilayer permeability of polymersomes
by measuring the amount of calcein released from the polymersome during
the incubation in deionized water or 10% (v/v) plasma solution. Calcein
is a fluorescein derivative that self-quenches as its concentration
exceeds 2–3 mM.[20] Therefore, encapsulated
calcein at high concentrations self-quenches within polymersomes,
while that released into the media generates fluorescence emission.[21,22] As such, the suspension of polymersomes with the lower bilayer permeability
should show a slower recovery of calcein fluorescence than those with
the higher bilayer permeability. As expected, MA-2.7 polymersomes
with the cross-linked bilayer showed a smaller increase of fluorescence
intensity than MA-2.7 polymersomes without the cross-linked bilayers,
especially when the particles were incubated in 10% (v/v) plasma aqueous
solution (Figure 2c). In addition, increasing
the DSMA from 2.7 to 4.8 mol % significantly limited the
fluorescence recovery both in deionized water and in the 10% plasma
solution, even without cross-linking the bilayer. Interestingly, at
the high DSMA, chemical cross-linking of the bilayer did
not make a difference in the fluorescence recovery rate (Figure 2c).Biochemical stability of PHEA-based polymersomes
was evaluated
by monitoring changes of the particle radius while the polymersomes
were incubated in PBS at 37 °C. MA-2.7 and MA-4.8 polymersomes
displayed better stability than MA-0.0 polymersomes, even without
cross-linking the bilayer. The MA-0.0 polymersomes in PBS disappeared
within 48 h, following a 2-fold increase of the average RH (Figure 3a). In contrast, MA-2.7
and MA-4.8 polymersomes without cross-linked bilayers retained their
original size over 12 days (open squares in Figure 3b and c). Interestingly, increasing DSMA significantly
lessened the growth of RH over time. Specifically,
the RH of MA-2.7 polymersomes increased
from 108 to 214 nm within 1 day, followed by a gradual increase to
230 nm over the following 11 days (open squares in Figure 3b). In contrast, the RH of MA-4.8 polymersomes increased from 89 to 121 nm in the first
day, followed by a minimal increase of RH over time (open squares in Figure 3c).
Figure 3
Stability analysis
of polyaspartamide polymersomes with dynamic
light scattering (DLS). The changes in the hydrodynamic radius (RH) of the polymersomes of (a) MA-0.0, (b) MA-2.7,
and (c) MA-4.8. The polymersomes were incubated in PBS at 37 °C.
The filled and open squares represent the polymersomes with bilayers
in which methacrylate groups were cross-linked and not cross-linked,
respectively. *After 2 days, RH of MA-0.0
polymersomes could not be measured with DLS.
Stability analysis
of polyaspartamide polymersomes with dynamic
light scattering (DLS). The changes in the hydrodynamic radius (RH) of the polymersomes of (a) MA-0.0, (b) MA-2.7,
and (c) MA-4.8. The polymersomes were incubated in PBS at 37 °C.
The filled and open squares represent the polymersomes with bilayers
in which methacrylate groups were cross-linked and not cross-linked,
respectively. *After 2 days, RH of MA-0.0
polymersomes could not be measured with DLS.Further cross-linking of the polymersome bilayer reduced
the degree
of increase in RH, depending on DSMA. The RH of MA-2.7 polymersomes
with a cross-linked bilayer exhibited an increase from 100 to 200
nm within the first 24 h and remained constant over the following
11 days (filled squares in Figure 3b), which
showed a lessened expansion than the RH of the MA-2.7 polymersome without a cross-linked bilayer. In contrast,
there was a minimal difference of the size change profile between
the MA-4.8 polymersome with a cross-linked bilayer and that without
a cross-linked bilayer (Figure 3c).Incubating
polymersomes at 90 °C, which is above the melting
temperature of the polymer (Supporting Information
Figure S3), also demonstrated different structural disintegration
rates between the particles with a cross-linked bilayer and those
without. The MA-0.0 polymersome disappeared within 1 day (Supporting Information Figure S4a). In contrast,
both MA-2.7 and MA-4.8 polymersomes with cross-linked bilayers showed
limited size changes (Supporting Information Figure
S4b and S4c), while MA-4.8 polymersomes with a cross-linked
bilayer had the smallest change on its size distribution before and
after being incubated at the evaluated temperature. Additionally,
these polymersomes demonstrated little, if any, cellular toxicity
according to an analysis of cellular metabolic activity using MTT
reagent. Endothelial cells incubated with 0.25 or 0.01 mg/mL of MA-2.7
or MA-4.8 polymersomes retained a level of metabolic activity similar
to untreated cells (Supporting Information Figure
S5).
Functionalization of Polymersomes with an
NIR Fluorescent Probe
and In Vivo Assessment
The polymersomes of MA-2.7 and MA-4.8
were functionalized with an NIR fluorescent probe, FPR-675, in order
to use the particles as a tool to detect and image pathologic tissue
innervated by abnormal, leaky vasculature. The sulfonic acid group
of FPR-675 was conjugated to the hydroxyl group of PHEA-C18-MA via esterification (Supporting Information
Scheme S1). Accordingly, the polymersome suspension displayed
an absorbance peak at 675 nm (Figure 4a), as
well as NIR fluorescence emission at 700 nm upon excitation at 675
nm (Figure 4b).
Figure 4
Characterization of PHEA-C18-MA polymersomes modified
with the NIR probe, FPR-675. (a) UV–visible spectrum of MA-2.7
conjugated with FPR-675. (b) The NIR fluorescence image of (I) free
FPR-675 solution, (II) FPR-675-labeled MA-2.7 polymersome suspension,
and (III) FPR-675-labeled MA-4.8 polymersome suspension. The methacrylate
groups in the bilayers of polymersomes were cross-linked.
Characterization of PHEA-C18-MA polymersomes modified
with the NIR probe, FPR-675. (a) UV–visible spectrum of MA-2.7
conjugated with FPR-675. (b) The NIR fluorescence image of (I) free
FPR-675 solution, (II) FPR-675-labeled MA-2.7 polymersome suspension,
and (III) FPR-675-labeled MA-4.8 polymersome suspension. The methacrylate
groups in the bilayers of polymersomes were cross-linked.Next, the ability of FPR-675-labeled PHEA-C18-MA polymersomes
to image tumor tissue was evaluated by systemically injecting them
into circulation of a tumor-bearing mouse model and imaging the whole
body with a real-time NIR fluorescence imaging system. The tumor was
created by subcutaneously injecting squamous cell carcinoma (SCC7)
into the back of a mouse. Injection of free FPR-675 solution via tail
vein yielded a low level of positive fluorescence in tumor sites throughout
48 h. The fluorescence intensity from the tumor site was comparable
to the autofluorescence level of the neighboring tissue, thus making
it difficult to distinguish tumor from the normal tissue (Figure 5a–i).
Figure 5
In vivo evaluation of PHEA-C18-MA polymersomes in targeting
and imaging tumors. (a) NIR fluorescence images of tumor-bearing mice
after the intravenous injection of (I) free FPR-675 probes, (II) FPR-675-labeled
MA-2.7 polymersomes without cross-linked bilayers, and (III) FPR-675-labeled
MA-2.7 polymersomes with cross-linked bilayers. Arrows mark the tumor
site. (b) NIR fluorescence intensity changes over 48 h in the tumor
tissues of the corresponding mouse shown in part a. (black square)
represents free FPR-675 dye, (red circle) represents FPR-675-labeled
MA-2.7 polymersomes without cross-linked bilayers, and (blue triangle)
represents FPR-675-labeled MA-2.7 polymersomes with cross-linked bilayers.
(c) NIR fluorescence intensities of the ex vivo organ images from
the tumor-bearing mice 48 h after the injection. The black, red, and
blue bars represent free FPR-675 dye, FPR-675-labeled MA-2.7 polymersomes
without cross-linked bilayers, and FPR-675-labeled MA-2.7 polymersomes
with cross-linked bilayers, respectively.
In contrast, FPR-675-labeled
MA-2.7 polymersomes without a cross-linked
bilayer made a 1.4-fold increase of the fluorescence intensity compared
to the free FPR-675 solution (Figure 5a and
b). Although the fluorescence from the FPR-675-labeled MA-2.7 polymersome
without a cross-linked bilayer in the tumor site gradually decreased
throughout 48 h, it was kept at a higher level than that of a mouse
injected with the free FPR-675 solution. In addition, the FRP-675-labeled
MA-2.7 polymersome with a cross-linked bilayer generated 1.6 times
higher fluorescence intensity at the tumor site compared to the MA-2.7
polymersome without cross-linking 1 h after injection (Figure 5b). This represented the highest intensity among
the three injections over 48 h, making the tumor site clearly distinguished
from the normal neighboring tissue (Figure 5a-III). However, further decreasing the permeability of the polymersome
bilayer by increasing DSMA made minimal enhancements in
elevating the fluorescence intensity in cancer sites over time (Supporting Information Figure S6).Biodistribution
of free FPR-675 and FPR-675-labeled polymersomes
were evaluated with NIR fluorescence images of multiple organs including
liver, lung, spleen, kidney, heart, and tumor, all of which were collected
48 h after the injection. Similar to the real time imaging, the highest
NIR fluorescence of the ex vivo tumor was achieved with the FPR-675-labeled
MA-2.7 polymersome with a cross-linked bilayer (Figure 5c). Additionally, the difference in NIR fluorescence between
the tumor tissue and other organs, with the exception of the kidney,
was also largest with the FPR-675-labeled, bilayer cross-linked MA-2.7
polymersome. Interestingly, absence of the cross-linked structure
in the polymersome bilayer caused the particles to accumulate more
in the kidney than in tumor tissue.In vivo evaluation of PHEA-C18-MA polymersomes in targeting
and imaging tumors. (a) NIR fluorescence images of tumor-bearing mice
after the intravenous injection of (I) free FPR-675 probes, (II) FPR-675-labeled
MA-2.7 polymersomes without cross-linked bilayers, and (III) FPR-675-labeled
MA-2.7 polymersomes with cross-linked bilayers. Arrows mark the tumor
site. (b) NIR fluorescence intensity changes over 48 h in the tumor
tissues of the corresponding mouse shown in part a. (black square)
represents free FPR-675 dye, (red circle) represents FPR-675-labeled
MA-2.7 polymersomes without cross-linked bilayers, and (blue triangle)
represents FPR-675-labeled MA-2.7 polymersomes with cross-linked bilayers.
(c) NIR fluorescence intensities of the ex vivo organ images from
the tumor-bearing mice 48 h after the injection. The black, red, and
blue bars represent free FPR-675 dye, FPR-675-labeled MA-2.7 polymersomes
without cross-linked bilayers, and FPR-675-labeled MA-2.7 polymersomes
with cross-linked bilayers, respectively.
Discussion
In summary, this study demonstrates an advanced
method to improve
the imaging of pathologic, tumor tissue using PHEA-C18-MA
polymersomes engineered to present less permeable bilayers. The bilayer
permeability was decreased by introducing more numbers of methacrylate
groups into the bilayer of the polymersome without cross-linking treatment,
and also by further cross-linking the bilayer. We found that the polymersome
with a larger DSMA (MA-4.8 polymersome) was more stable
in physiological media than that without methacrylate groups (MA-0.0
polymersome) and that with a smaller DSMA (MA-2.7 polymersome),
even without cross-linking treatment. Additionally, the cross-linking
of the bilayer further decreased the permeability and enhanced the
stability of the polymersome compared to its uncross-linked form,
but only for the MA-2.7 polymersome. Lastly, the MA-2.7 polymersome
that was modified to carry an NIR fluorescent probe and present a
cross-linked bilayer significantly improved the imaging quality of
tumor sites over 48 h after systemic injection.According to
previous studies, polymersomes should disassemble
more slowly than liposomes of a similar CAC when the concentration
falls below the CAC.[23−25] However, the complete disappearance of PHEA-C18 polymersomes in PBS within 48 h implies that increasing
the molecular weight of self-assembling molecules does not perfectly
circumvent the structural disassembly on a long-term basis. We propose
that methacrylate groups linked to the PHEA-C18polymer
backbone hydrophobically associate with each other in the confined
bilayer together with octadecyl chains, due to the mismatch of Hildebrand
solubility parameter between ethyl methacrylate (8.61 (cal/cm3)1/2)[26] and water (23.5
(cal/cm3)1/2).[27] Additionally,
it is unlikely that these methacrylate groups impair the vesicular
structure of PHEA-C18-MA, as confirmed with TEM micrographs
and supported by theoretical calculation (Supporting
Information Table S1).[28−30] We suggest that both the hydrophobic
association and the pH-independent cross-linking bonds between methacrylate
groups greatly serve to improve particle stability and subsequent
targeted imaging quality, whereas other cross-linking bonds such as
hydrazine and disulfide bonds may disintegrate in tissue with pH deviating
from neutral. Therefore, methacrylate groups incorporated into the
bilayer likely played a similar role as cholesterol in phospholipid
liposome bilayers. It is well agreed that cholesterol reduces the
free space in bilayers,[31,32] and subsequently enhances
liposome stability.[33] Similarly, increasing
the packing density should decrease the bilayer permeability and further
decelerate the structural disintegration of polymersomes caused by
dilution effects, as manifested with the slower calcein release from
MA-4.8 than MA-2.7 polymersomes without cross-linking and the smallest
size increase of MA-4.8 polymersomes. We therefore interpret that
the stability achieved by increasing DSMA is due to the
increase of packing density in the bilayer. Additionally, the decrease
of RH with increasing DSMA should
be attributed to an increase of the hydrophobic association between
polymers and the subsequent formation of a more compact bilayer.Additionally, cross-linking of the bilayer has further enhanced
the MA-2.7 polymersome stability exclusively. The slower recovery
of fluorescence from calcein in the MA-2.7 polymersome with a cross-linked
bilayer can be attributed to the decreased bilayer permeability, while
the limited size increase of MA-2.7 polymersomes with a cross-linked
bilayer over time indicates that the particle has a greater resistance
to structural disintegration. In contrast, the independence of the
bilayer permeability and particle size change on the cross-linking
of the MA-4.8 polymersome bilayer is likely due to the high packing
density of the bilayer negating the effect of cross-linking.Taken together, we propose that the control of bilayer permeability
and particle stability serve to improve the quality of NIR fluorescence
imaging of cancerous tissues. Prior studies on the EPR effect suggested
that particle diameters should be smaller than 400 nm.[34,35] The size of PHEA-C18-MA polymersomes used in this study
fit within this particle size range. However, it is likely that lipids
in blood serum accelerate the expansion or disassembly of MA-2.7 polymersomes
without cross-linked bilayers,[15,16,36] thus limiting the accumulation of particles in the tumor site via
the EPR effect as well as accelerating the renal clearance of disassembled
monomers due to the low molecular weight.[37] Additionally, the accumulated particles in the tumor site can be
degraded gradually and hence the fluorescence of the area of interest
decreased. In contrast, the MA-2.7 polymersome with a cross-linked
bilayer should remain stable in circulation over an extended time
period to extravasate through leaky tumor vasculature, and the accumulated
particles in the tumor site, while still degradable, were degraded
slower than the polymersome without cross-linked bilayers.Previously,
some studies demonstrated that cross-linking the bilayer
of a microsized gigantic polymersome results in increasing the surface
elastic modulus, wall stress, and resistance to surfactant-induced
disassembly than traditional liposomes.[38,39] However, no
efforts have been made to improve detection and imaging of cancer
tissue by translating these findings into the assembly of nanosized
polymersomes to date. Therefore, we envisage that our finding will
be very useful to designing nanoparticles used for diagnostics and
also treatment of various acute and malignant diseases, including
cancer and cardiovascular diseases.[40,41] Further extending
the lifetime of polymersomes in circulation, as well as the time window
for cancer imaging with a single dose, could potentially be achieved
by conjugating PEG chains to the PHEA-C18-MA polymersome.
The quality of image-guided diagnostics will be further improved by
conjugating peptides or antibodies that can specifically bind with
target cells to the polymersomes developed in this study. On a separate
note, though PHEA-C18-MA polymersomes have been shown to
demonstrate limited toxicity to the mouse endothelial cells, further
investigation is needed to evaluate performance in humans.
Conclusion
In summary, this study demonstrated a nanoparticle platform engineered
to present a reduced permeability that is useful for significantly
improving the detection and imaging of pathologic tissue. The methacrylate
groups attached to a self-assembling polyaspartamide polymer served
to reduce the bilayer permeability, likely because they associated
with other hydrophobic alkyl chains and increased the packing density.
Cross-linking of the methacylate groups postassembly of the nanoparticles
further reduced the bilayer permeability, thus leading to another
increase of the particle stability in physiological media, exclusively
at an intermediate degree of substitution for methacrylate groups
to the polymer. Therefore, the polymersome conjugated with an NIR
fluorescent probe and tailored to display reduced permeability significantly
improved the imaging quality of tumor sites over 48 h after systemic
injection. These results certify the importance of extending the lifetime
of nanoparticles in improving their function in detecting and imaging
pathologic tissues of interest. Finally, the polymersomes with a tailored
permeability will be useful in future studies to modulate the release
rate of various therapeutic molecules and ultimately improve the quality
of diagnosis and treatment of diverse diseases.
Experimental
Section
Materials were purchased from Sigma-Aldrich (U.S.A.)
and used without
further purification unless otherwise specified.
Synthesis of Poly(2-hydroxyethyl-co-octadecyl
aspartamide) (PHEA-C18) and Poly(2-hydroxyethyl-co-2-methacryloxyethyl-co-octadecyl aspartamide)
(PHEA-C18-MA)
Polysuccinimide (PSI) was synthesized
by thermal condensation of L-aspartic acid (30 g)
suspended in sulfolane (150 mL) at 170 °C under a nitrogen atmosphere
for 14 h with phosphoric acid (0.612 mL, Fisher Scientific) as a catalyst.[18] PSI was precipitated in excess methanol and
successively washed with deionized water until the pH of the suspension
reached neutral. The precipitate was dried by lyophilization. The
molecular weight of PSI was determined by gel permeation chromatography
(Breeze 2 GPC, Waters), with Styragel HT column (Waters). -dimethylformamide (DMF) containing
20 mM LiBr was used as the eluent, with the elution rate of 1 mL min.
Polystyrene standards were used for calibration. Mn = 13,600 g mol with PDI = 1.4.Purified PSI (79
mg) was dissolved in DMF (5 mL, Fisher Scientific), and octadecylamine
(79 mg for MA-0.0, MA-2.7, and MA-4.8, respectively) was added to
the reaction mixture. The reaction was stirred at 70 °C for 24
h. Next, a designated amount of 2-aminoethyl methacrylate hydrochloride
(AEMA) (0 μL for MA-0.0, 195 μL for MA-2.7, and 391 μL
for MA-4.8) and triethylamine (TEA, Fisher Scientific) (0 μL
for MA-0.0, 10.6 μL for MA-2.7, and 21.2 μL for MA-4.8)
were added to the reaction mixture, and the solution was stirred at
45 °C for 24 h. The molar ratio of AEMA to TEA was 1:3. Lastly,
an excess amount of ethanolamine was added (96.8 μL for MA-0.0,
82.3 μL for MA-2.7, and 75.4 μL for MA-4.8) and the reaction
was further stirred at 45 °C overnight. Following completion
of the chemical reactions, the products were dialyzed (MWCO 3500 Da,
Fisher Scientific) extensively in deionized water at room temperature
for 2 days and then lyophilized to yield dry powders.
Measurement
of the Critical Aggregation Concentration (CAC)
Pyrene molecules
(Acros) were suspended at a concentration of 10−4 mg/mL in the polymer solution. The fluorescence spectra
of the suspensions with varying polymer concentrations were collected
using a FluoroMax-4 spectrometer (HORIBA Jobin Yvon). The excitation
wavelength was set at 330 nm and the resulting emission between 350
and 450 nm was collected; the slit widths for excitation and emission
were both set as 1 nm. The CAC was determined by the polymer concentration
at the point where the emission intensity ratio (I3/I1) between the third vibronic peak at 385 nm (I3) and the first vibronic peak at 373 nm (I1) was significantly
increased.[19]
Synthesis of PHEA-C18-MA Labeled with FPR-675
FPR-675 (5 μmol)
(BioActs) was dissolved in 500 μL of
DMSO (Merck) and added dropwise to PHEA-C18-MA dissolved
in DMSO (10 mg in 2 mL). The reaction mixture was stirred overnight
at room temperature in the dark. The products were dialyzed extensively
in deionized water with light protection at room temperature to remove
the free dye and DMSO, and then lyophilized to yield dry powders.
The resulting polymers were analyzed with a UV/vis spectrophotometer
Lambda 7 (PerkinElmer).
Preparations of PHEA-C18 and PHEA-C18-MA
Polymersomes
PHEA-C18-MApolymers and Irgacure
2959 (Ciba Specialty Chemicals) were dissolved in DMSO at a concentration
10 and 100 mg mL, respectively. 100 μL polymer in DMSO was mixed
with 20 μL initiator in DMSO, and the mixture was dropped into
1 mL deionized water. The solution was sonicated for 10–15
s and then dialyzed in deionized water extensively to remove DMSO
and excess initiator overnight. During dialysis, the suspension was
covered with aluminum foil to prevent exposure to light. The purified
suspension was finally exposed to UV light (Model 20 CHIPhERASER,
Jelight Co. Inc.) for 5 min to cross-link the bilayer of the polymersome.
Separately, in preparation of PHEA-C18 or PHEA-C18-MA polymersomes without cross-linked bilayers, Irgacure 2959 was
not mixed with the polymer solution; nor was the polymersome suspension
exposed to UV light. In the stability analysis, 10× phosphate
buffered saline (PBS) was added to adjust the ionic strength of the
polymersome suspension to 1× PBS after the particle preparation.
Characterization of PHEA-C18 and PHEA-C18-MA
Polymersomes
The morphology of self-assembled PHEA-C18-MA polymersomes was observed using TEM (JEOL 2100 with LaB6 emitter) operating at an accelerating voltage of 120 keV.
The polymersome suspension was dropped onto a 300-mesh copper grid
coated with carbon and Formvar (SPI Supplies), and the sample was
stained with 2% (w/v) phosphotungstic acid solution (adjusted to pH
7.4 with NaOH). The size of PHEA-C18-MA polymersomes was
measured using a Malvern Zetasizer Nano ZS (Malvern, 4 mW He–Ne
laser operating at a wavelength of 633 nm) with 173° backscattering.
The hydrodynamic radius was determined using cumulant analysis (International
Organization for Standardization 13321:1996). All measurements were
carried out in triplicate and performed at 25 °C.
Calcein Release
Study
PHEA-C18-MA polymersomes
were prepared by the solvent exchange process. Then, 50 mM calcein
(Fisher Scientific) aqueous solution was added slowly into the polymersome
suspension to a final concentration of 25 mM for diffusional loading.
The suspension was incubated at room temperature with stirring for
1 day for calcein to reach equilibrium, and exposed to UV light to
activate the cross-linking reaction in the bilayer of polymersomes.
Certain polymersome suspensions were not exposed to UV light for a
control experiment. The excess calcein that was not incorporated into
the polymersomes was removed by Amicon Ultra-0.5 Centrifugal Filter
Devices (MWCO 100k Da, Millipore Corporation). The polymersomes were
incubated within deionized water or deionized water supplemented by
10% (v/v) human plasma (Equitech-Bio Inc.). After incubation for 30
min at room temperature, the amount of calcein released from the polymersome
was measured with the emission intensity at 535 (±20) nm at the
excitation of 485 (±20) nm using a microplate reader (Infinite
200Pro, Tecan Group Ltd.).
In Vivo Noninvasive NIR Fluorescence Imaging
of Polymersomes
in Tumor-Bearing Mice
All animal experiments were performed
in compliance with the guidelines approved by the institutional ethics
committee for animal care of Korea Institute of Science and Technology
(KIST). To generate a tumor-bearing mouse model, squamous cell carcinoma
(SCC7) tumors were induced into 5-week-old male athymic nude mice
(Institute of Medical Science, Tokyo) by subcutaneous injection of
1.0 × 106 SCC7 cells. When the tumor diameter grew
to approximately 10 mm, the test samples (5 mg kg) were injected into
the tumor-bearing mice through the tail vein, and the whole body images
were taken at 1, 3, 6, 12, 24, and 48 h after the injection, using
a time-domain fluorescence imager eXplore Optix (ART Advanced Research
Technologies Inc.). Laser power and count time settings were optimized
at 9 μW and 0.3 s per point. Excitation and emission spots were
raster-scanned in 1 mm steps over the selected region of interest
to generate emission wavelength scans. A 675 nm pulsed laser diode
was used to excite FPR-675 molecules. NIR fluorescence emission at
700 nm was collected and detected with a fast photomultiplier tube
(Hamamatsu) and a time-correlated single photon counting system (Becker
and Hickl GmbH). NIR fluorescence intensities of all samples were
adjusted to the same values based on the data obtained by a 12-bit
CCD camera (Kodak Imaging Station 4000 MM, New Haven) equipped with
a C-mount lens and a Cy5.5 bandpass emission filter set (680 to 720
nm, Omega Optical). Furthermore, the accumulation level of samples
in the tumors was evaluated by measuring the NIR fluorescence intensity
at the cancer site. All data were processed using the region of interest
(ROI) function of the Analysis Workstation software (ART Advanced
Research Technologies Inc.).
Ex Vivo Organ Analysis
After intravenous
injection
of FPR-675 labeled polymersomes, major organs and tumors were dissected
from mice 48 h after the injection. NIR fluorescence images of dissected
organs including liver, lung, spleen, kidney, heart, and tumors were
obtained with Kodak Image Station 4000 MM. The image station was equipped
with a 12-bit CCD camera, halogen lamp (150 W), and excitation/emission
filter sets for FPR-675 (600–700 nm; Omega Optical). The biodistribution
of polymersomes was evaluated by quantifying the NIR fluorescence
intensity of the organ and tumor images processed with Kodak molecular
imaging software.
Authors: Biana Godin; Jason H Sakamoto; Rita E Serda; Alessandro Grattoni; Ali Bouamrani; Mauro Ferrari Journal: Trends Pharmacol Sci Date: 2010-02-19 Impact factor: 14.819
Authors: P Peter Ghoroghchian; Paul R Frail; Kimihiro Susumu; Dana Blessington; Aaron K Brannan; Frank S Bates; Britton Chance; Daniel A Hammer; Michael J Therien Journal: Proc Natl Acad Sci U S A Date: 2005-02-11 Impact factor: 11.205
Authors: Nicholas E Clay; Joseph J Whittenberg; Jiayu Leong; Vivek Kumar; Jinrong Chen; Insil Choi; Evangelos Liamas; Jeremy M Schieferstein; Jae Hyun Jeong; Dong Hyun Kim; Zhenyu Jason Zhang; Paul J A Kenis; Il Won Kim; Hyunjoon Kong Journal: Nanoscale Date: 2017-04-20 Impact factor: 7.790